
Enzymit is ushering in a new era of biomanufacturing with its cell-free enzymatic approach, offering a faster, more cost-effective, and sustainable alternative to traditional chemical manufacturing and fermentation-based processes. Leveraging proprietary enzyme design platform that utilizes advanced computational design algorithms, deep learning, and high-throughput testing, Enzymit creates novel biomolecular components to address unmet market needs. The company's technology is applied across various markets including biochemicals, food and beverages, personal care, and health and nutrition, with specific products like Human Milk Oligosaccharides (HMOs) and Hyaluronic Acid (HA) highlighted for their improved purity, yield, and simpler purification processes. Founded in 2020 by alumni of the Weizmann Institute of Science, Enzymit's team comprises experts in computational protein design, synthetic biology, generative AI, and bioengineering.

Enzymit is ushering in a new era of biomanufacturing with its cell-free enzymatic approach, offering a faster, more cost-effective, and sustainable alternative to traditional chemical manufacturing and fermentation-based processes. Leveraging proprietary enzyme design platform that utilizes advanced computational design algorithms, deep learning, and high-throughput testing, Enzymit creates novel biomolecular components to address unmet market needs. The company's technology is applied across various markets including biochemicals, food and beverages, personal care, and health and nutrition, with specific products like Human Milk Oligosaccharides (HMOs) and Hyaluronic Acid (HA) highlighted for their improved purity, yield, and simpler purification processes. Founded in 2020 by alumni of the Weizmann Institute of Science, Enzymit's team comprises experts in computational protein design, synthetic biology, generative AI, and bioengineering.